Evidence map›Paper›PMID 22745239›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2012

Ghrelin stimulation of growth hormone isoforms: parallel secretion of total and 20-kDa growth hormone and relation to insulin sensitivity in healthy humans.

Jenny Tong, David D'Alessio, Juliane Ramisch, Harold W Davis, Elizabeth Stambrook, Matthias H Tschöp, Martin Bidlingmaier

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Clinical review: The human experience with ghrelin administration.The Journal of clinical endocrinology and metabolism · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jenny TongDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Cincinnati, Cincinnati, Ohio 45267, USA. jenny.tong@uc.edu
David D'Alessio
Juliane Ramisch
Harold W Davis
Elizabeth Stambrook
Matthias H Tschöp
Martin Bidlingmaier
University of Cincinnati · USLudwig-Maximilians-Universität München · DEHelmholtz Zentrum München · DE

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR026314 · NCRR · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2009 to 2011
$14.3M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2012 to 2014
$9.9M
Impact of Ghrelin of Beta-cell Function and Insulin Sensitivity in HumansK23DK080081 · NIDDK · UNIVERSITY OF CINCINNATI · PI TONG, JENNY · 2007 to 2011
$865k
The Impact of Unacylated Ghrelin on Insulin Secretion and Glucose Tolerance in HuR03DK089090 · NIDDK · UNIVERSITY OF CINCINNATI · PI TONG, JENNY · 2010 to 2011
$156k
NCATS NIH HHS UL1 TR000077NCRR NIH HHS UL1 RR026314NIDDK NIH HHS 1R03DK89090NIDDK NIH HHS 5K23DK80081NIDDK NIH HHS K23 DK080081NIDDK NIH HHS R03 DK089090
6 · The paper itself

Abstract

contextThe 20-kDa human GH (hGH) is produced in the pituitary by alternative splicing of the hGH-N gene. The 20-kDa hGH promotes growth similarly to 22-kDa or total hGH, the predominant form in circulation, but the relative effects of these isoforms on glucose metabolism have been debated.

objectiveTo investigate the effect of ghrelin on 20-kDa and total hGH secretion in healthy, nonobese subjects. We also studied associations between basal GH concentration and fasting glucose and insulin as well as between dynamic GH secretion and insulin sensitivity. DESIGN AND

settingSynthetic human acyl ghrelin (0.2 or 0.6 nmol/kg · h) or saline was infused in random order in 14 healthy subjects (six males, eight females; age 27.7 ± 6.3 yr; body mass index 22.0 ± 2.7 kg/m(2), mean ± SEM) on 3 separate days. Ghrelin was infused for 45 min to achieve steady-state levels and continued through a 3-h frequently sampled i.v. glucose tolerance test. Insulin sensitivity index was quantified using the minimal model of glucose kinetics.

resultsBasal 20-kDa and total GH concentrations were 0.4 ± 0.1 and 2.2 ± 0.4 ng/ml, respectively, with a 20-kDa to total GH ratio of 0.13 ± 0.02. Females had significantly higher baseline GH levels. Ghrelin administration increased 20-kDa and total GH levels in a parallel and dose-dependent fashion, with no significant change in the ratio of the isoforms. Basal 20-kDa and total GH levels were negatively correlated with fasting glucose, insulin, and homeostasis model assessment of insulin resistance. During the frequently sampled iv glucose tolerance test, GH secretion was positively correlated with insulin sensitivity index with saline infusion.

conclusionGhrelin dose-dependently increases endogenous 20-kDa and total GH secretion in a parallel fashion in healthy subjects. Both basal and stimulated levels of the different GH isoforms were positively associated with insulin sensitivity in this cohort of healthy men and women.

Indexed as

AdolescentAdultBlood GlucoseDose-Response Relationship, DrugFemaleGhrelinHomeostasisHuman Growth HormoneHumansInsulinInsulin ResistanceIsomerismLuminescenceMaleRadioimmunoassayYoung AdultBlood GlucoseGhrelinHuman Growth HormoneInsulin

Identifiers

PMID22745239
PMCPMC3431574
OpenAlexW2124172190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.